Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals

Bibliography

• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang X, Brown J, Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:293-301
   PubMed Web of Science ®Google Scholar
• Morrow AS, Haidet P, Skinner J, Integrating diabetes self-management with the health goals of older adults: a qualitative exploration. Patient Educ Couns 2008;72:418-23
   PubMed Web of Science ®Google Scholar
• Lernmark A. Type 1 diabetes. Clin Chem 1999;45:1331-8
   PubMedGoogle Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• Wright A, Burden AC, Paisey RB, Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6
   PubMed Web of Science ®Google Scholar
• Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 2008;121:S35-41
   PubMed Web of Science ®Google Scholar
• Donnelly LA, Morris AD, Evans JM. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007;100:345-50
   PubMed Web of Science ®Google Scholar
• Morris AD, Boyle DI, McMahon AD, Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes audit and research in tayside Scotland. medicines monitoring Unit. Lancet 1997;350:1505-10
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Kruger DF, Correlates of insulin injection omission. Diabetes Care 2010;33:240-5
   PubMed Web of Science ®Google Scholar
• Randlov J, Poulsen JU. How much do forgotten insulin injections matter to hemoglobin a1c in people with diabetes? A simulation study. J Diabetes Sci Technol 2008;2:229-35
   PubMedGoogle Scholar
• Hokkam EN. Assessment of risk factors in diabetic foot ulceration and their impact on the outcome of the disease. Prim Care Diabetes 2009;3:219-24
   PubMedGoogle Scholar
• Landman GW, van Hateren KJ, Kleefstra N, The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract 2010;60:172-5
   PubMed Web of Science ®Google Scholar
• Lind M, Bounias I, Olsson M, Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 2011;378:140-6
   PubMed Web of Science ®Google Scholar
• Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106:57-8; 61-4, 8
   PubMed Web of Science ®Google Scholar
• IMS Health. Estimated number of patients using FlexPen®, based on worldwide sales in number of packs sold, IMS world wide data Q3'08 and Daily Defined Dosage (DDD) for insulin as issued by WHO; 2008
   Google Scholar
• Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child 1998;79:59-62
   PubMed Web of Science ®Google Scholar
• Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74
   PubMed Web of Science ®Google Scholar
• Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Bell D, Jacobsen C, A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48
   PubMed Web of Science ®Google Scholar
• Lombardo F, Salzano G, Messina MF, Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66-9
   PubMedGoogle Scholar
• Olsen BS, Lilleore SK, Korsholm CN, Novopen Echo for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents and health care professionals. J Diabetes Sci Tech 2010;4:1468-75
   PubMedGoogle Scholar
• Sommavilla B, Jorgensen C, Jensen KH. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2223-32
   PubMed Web of Science ®Google Scholar
• Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
   PubMed Web of Science ®Google Scholar
• Pfutzner A. FlexPen for the delivery of insulin: accuracy, injection force and patient preference. Expert Rev Med Devices 2009;6:115-23
   PubMed Web of Science ®Google Scholar
• Baser O, Bouchard J, DeLuzio T, Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe. Adv Ther 2010;27:94-104
   PubMed Web of Science ®Google Scholar
• Asakura T, Seino H, Jensen KH. NovoPen® 4 is easier to teach, more intuitive to use and preferred by patients compared to OptiClik®.. Diabetes 2006;55:A456
   Web of Science ®Google Scholar
• Donsmark M, Herold L, Kristensen CM. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4. Diabetes Technol Ther 2009;11:581-5
   PubMed Web of Science ®Google Scholar
• Kristensen CM, Donsmark M. Dose accuracy and durability of the NovoPen 4 insulin delivery device before and after simulation of 5 years of use and under various stress conditions. Clin Ther 2009;31:2819-23
   PubMed Web of Science ®Google Scholar
• Asakura T, Seino H, Jensen KH. Patient acceptance and issues of education of two durable insulin pen devices. Diabetes Technol Ther 2008;10:299-304
   PubMed Web of Science ®Google Scholar
• Israel-Bultman H, Hyllested-Winge J, Kolaczynski M, Comparison of preference for NovoPen((R)) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study. Clin Ther 2011;33:346-57
   PubMed Web of Science ®Google Scholar
• World Medical Association. Declaration of Helsinki - ethical principles for medical research involving human subjects. 2008. Available from: http://wwwriip-influenzaorg/wp-content/uploads/2011/08/Helsinki-2008-ENpdf [Accessed 8 November 2011]
   Google Scholar
• Buus P, Lilleore SK, Larsen K. Compatibility testing of two types of pen needles with a range of injection pens for diabetes medication. Curr Med Res Opin 2011;27:589-92
   PubMed Web of Science ®Google Scholar
• Asakura T. Comparison of clinically relevant technical attributes of five insulin injection pens. J Diabetes Sci Technol 2011;5:1203-9
   PubMedGoogle Scholar
• Asakura T, Seino H. Assessment of dose selection attributes with audible notification in insulin pen devices. Diabetes Technol Ther 2005;7:620-6
   PubMedGoogle Scholar
• Chatzimarkakis J. Why patients should be more empowered: a European perspective on lessons learned in the management of diabetes. J Diabetes Sci Technol 2010;4:1570-3
   PubMedGoogle Scholar
• LaSalle JR. Empowering patients during insulin initiation: a real-world approach. J Am Osteopath Assoc 2010;110:69-78
   PubMedGoogle Scholar
• Rakel RE. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy. Adv Ther 2009;26:838-46
   PubMed Web of Science ®Google Scholar
• Serrano-Gil M, Jacob S. Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap? Adv Ther 2010;27:321-33
   PubMed Web of Science ®Google Scholar
• Bastian MD, Wolters NE, Bright DR. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes. Consult Pharm 2011;26:426-9
   PubMedGoogle Scholar
• Adolfsson P, Huot C, Veijola R, Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes - the REMIND study. Pediatr Diabetes 2011;12(Suppl 15):49
   Google Scholar
• Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycaemia. Diabetes Care 2005;28:1245-9
   PubMed Web of Science ®Google Scholar
• Fidler C, Elmelund Christensen T, Gillard S. Hypoglycemia: An overview of fear of hypoglycemia, quality-of-life, and impact on costs. J Med Econ 2011;14:646-55
   PubMedGoogle Scholar
• Alvarez Guisasola F, Tofe Povedano S, Krishnarajah G, Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab 2008;10(Suppl 1):25-32
   PubMed Web of Science ®Google Scholar